1
0
0
News
Anaveon appoints Dr Eduard Gasal as Chief Medical OfficerANAVEON
anaveon.com
Basel, November 30, – Anaveon, a clinical stage, immuno-oncology company, today announced the appointment of Dr Eduard Gasal as Chief Medical Officer ... Basel, November 30, – Anaveon, a clinical stage, immuno-oncology company, today announced the appointment of Dr Eduard Gasal as Chief Medical Officer ...
Anaveon announces IND approval of ANV (EXPAND) ...GlobeNewswire
www.globenewswire.com
“Approval to start our first-in-human clinical study of ANV600 represents an important step towards validation of our approach,” said Eduard Gasal, M.D., Chief ... “Approval to start our first-in-human clinical study of ANV600 represents an important step towards validation of our approach,” said Eduard Gasal, M.D., Chief ...
Anaveon announces IND approval of ANV GlobeNewswire
www.globenewswire.com
— ... Eduard Gasal, M.D., Chief Medical Officer of Anaveon. “In preclinical studies, ANV600 has demonstrated marked efficacy and a favorable — ... Eduard Gasal, M.D., Chief Medical Officer of Anaveon. “In preclinical studies, ANV600 has demonstrated marked efficacy and a favorable ...
Netzwerk-Profile
LinkedIn: Eduard Gasal | LinkedIn
Eduard Gasals berufliches Profil anzeigen LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und Führungskräften wie Eduard Gasal dabei hilft ...
LinkedIn: Eduard Gasal – ANAVEON AGLinkedIn · Eduard Gasal1530+ Follower
Berufserfahrung: ANAVEON AG · Ausbildung: University of Zurich · Ort: Basel · 500+ Kontakte auf LinkedIn. Sehen Sie sich das Profil von Eduard Gasal Eduard ... Basel, Basel, Schweiz · ANAVEON AGBerufserfahrung: ANAVEON AG · Ausbildung: University of Zurich · Ort: Basel · 500+ Kontakte auf LinkedIn. Sehen Sie sich das Profil von Eduard Gasal Eduard ...
Eduard Gasal — ASN EventsASN Events
cosa-ipos-2012.m.asnevents.com.au
3:00 PM. Eduard Gasal. COSA Posters: Clinical Research. ×Close. Contact. From: Hi ,. Attach Contact Details? Organise a meeting? Meeting Time. Location. 3:00 PM. Eduard Gasal. COSA Posters: Clinical Research. ×Close. Contact. From: Hi ,. Attach Contact Details? Organise a meeting? Meeting Time. Location.
Interessen
Progression-free Survival.The New England Journal of Medicine
www.nejm.org
Sci., Monique Tan, M.D., Eduard Gasal, M.D., Maurizio Voi, M.D., Dirk Schadendorf, M.D., and Georgina V. Long, M.B., B.S., Ph.D. N Engl J Med. Volume 381(7): ... Sci., Monique Tan, M.D., Eduard Gasal, M.D., Maurizio Voi, M.D., Dirk Schadendorf, M.D., and Georgina V. Long, M.B., B.S., Ph.D. N Engl J Med. Volume 381(7): ...
Adjuvant dabrafenib plus trametinib versus placebo in ...EM consulte
www.em-consulte.com
James Garrett, PhD, Catarina D Campbell, PhD, Eduard Gasal, MD, Matthew Squires, PhD, Daniel Gusenleitner, PhD, Mario Santinami, MD, Victoria Atkinson, MD, ... James Garrett, PhD, Catarina D Campbell, PhD, Eduard Gasal, MD, Matthew Squires, PhD, Daniel Gusenleitner, PhD, Mario Santinami, MD, Victoria Atkinson, MD, ...
Relapse-free Survival, According to Stage III Substage.The New England Journal of Medicine
www.nejm.org
D., Eduard Gasal, M.D., Monique Tan, M.D., Georgina V. Long, M.B., B.S., Ph.D., and Dirk Schadendorf, M.D.. N Engl J Med. Volume 383(12): September ... D., Eduard Gasal, M.D., Monique Tan, M.D., Georgina V. Long, M.B., B.S., Ph.D., and Dirk Schadendorf, M.D.. N Engl J Med. Volume 383(12): September ...
Management & Beteiligungen
Persons starting with EDMoneyhouse
www.moneyhouse.ch
Eduard Gasal · Eduard Gassmann · Eduard Gattlen · Eduard Gäumann · Eduard Gavrilita · Eduard gen. Eddie Lechleitner · Eduard gen. Eddy Agten · Eduard gen. Edi ... Eduard Gasal · Eduard Gassmann · Eduard Gattlen · Eduard Gäumann · Eduard Gavrilita · Eduard gen. Eddie Lechleitner · Eduard gen. Eddy Agten · Eduard gen. Edi ...
Business-Profile
Biography of Eduard GasalThe Official Board
www.theofficialboard.com
Learn about the role of Eduard Gasal, Chief Medical Officer at Anaveon. Full bio on The Official Board. Learn about the role of Eduard Gasal, Chief Medical Officer at Anaveon. Full bio on The Official Board.
Private Homepages
AboutANAVEON
anaveon.com
Andreas Katopodis. Co-Founder and CEO ; Christoph Huber. Chief Scientific Officer ; Eduard Gasal. Chief Medical Officer ; Gary Phillips. Chief Business Officer.
Bücher
Dabrafenib plus trametinib in patients with BRAFV600E-mutated ...Institut for Klinisk Medicin
ikm.ku.dk
author = "Vivek Subbiah and Ulrik Lassen and Eduard Gasal and Paul Burgess and Wainberg, {Zev A}",. year = "2020",. month = nov,. day = "1",. doi = " author = "Vivek Subbiah and Ulrik Lassen and Eduard Gasal and Paul Burgess and Wainberg, {Zev A}",. year = "2020",. month = nov,. day = "1",. doi = "
Dokumente zum Namen
AbstractAmerican Society of Clinical Oncology (ASCO)
meetings.asco.org
... Eduard Gasal, Dirk Schadendorf, Georgina V. Long. Organizations. Mount Vernon Cancer Centre, Northwood, United Kingdom, Paris-Sud University, Gustave Roussy Eduard Gasal, Dirk Schadendorf, Georgina V. Long. Organizations. Mount Vernon Cancer Centre, Northwood, United Kingdom, Paris-Sud University, Gustave Roussy ...
PosterAmerican Society of Clinical Oncology (ASCO)
meetings.asco.org
... Eduard Gasal, Richard Kefford, John M. Kirkwood, Georgina V. Long. Organizations. Department of Dermatology, University Hospital Essen, Essen, Germany Eduard Gasal, Richard Kefford, John M. Kirkwood, Georgina V. Long. Organizations. Department of Dermatology, University Hospital Essen, Essen, Germany ...
University of Groningen Phase 2 Study of Dabrafenib Plus ...Rijksuniversiteit Groningen
research.rug.nl
von D Planchard · · Zitiert von: 137 — Libero Santarpia, Monique Tan, Eduard Gasal,. Shirong Zhang: Project administration. Acknowledgments. This study was funded by Novartis Pharma AG, Basel,. von D Planchard · · Zitiert von: 137 — Libero Santarpia, Monique Tan, Eduard Gasal,. Shirong Zhang: Project administration. Acknowledgments. This study was funded by Novartis Pharma AG, Basel,.
Wissenschaftliche Veröffentlichungen
Articles Circulating tumour DNA in patients with advanced ...ScienceDirect.com
www.sciencedirect.com
von MM Syeda · · Zitiert von: 70 — Michael A Davies MD i , Prof Jean Jacques Grob MD j , Eduard Gasal MD k , Matthew Squires PhD l , Mahtab Marker PhD k , James Garrett PhD m , Jan C Brase PhD n von MM Syeda · · Zitiert von: 70 — Michael A Davies MD i , Prof Jean Jacques Grob MD j , Eduard Gasal MD k , Matthew Squires PhD l , Mahtab Marker PhD k , James Garrett PhD m , Jan C Brase PhD n
Dabrafenib plus trametinib in patients with BRAF>V600E ...Universität zu Lübeck
research.uni-luebeck.de
von PY Wen · · Zitiert von: 228 — ... Eduard Gasal, Vivek Subbiah Anzeigen 6 Sonstige Weniger anzeigen. *Korrespondierende/r Autor/-in für diese Arbeit. Klinik für Hämatologie und Onkologie ... von PY Wen · · Zitiert von: 228 — ... Eduard Gasal, Vivek Subbiah Anzeigen 6 Sonstige Weniger anzeigen. *Korrespondierende/r Autor/-in für diese Arbeit. Klinik für Hämatologie und Onkologie ...
Pembrolizumab with trametinib in patients with BRAF wild ...ScienceDirect.com
www.sciencedirect.com
von M Maio · · Zitiert von: 6 — ... Ferrucci i , Robert R. Zielinski j k , Michele Del Vecchio l , Eduard Gasal m , Razi Ghori n , Scott J. Diede n , Elizabeth Croydon n † , Omid Hamid ... von M Maio · · Zitiert von: 6 — ... Ferrucci i , Robert R. Zielinski j k , Michele Del Vecchio l , Eduard Gasal m , Razi Ghori n , Scott J. Diede n , Elizabeth Croydon n † , Omid Hamid ...
Phase 2 Study of Dabrafenib Plus Trametinib in Patients ...Archive ouverte HAL
hal.science
von D Planchard · · Zitiert von: 137 — ... Eduard Gasal , Libero Santarpia , Bruce E. Johnson. Afficher plus de détails. 1 IGR - Institut Gustave Roussy 2 Département de médecine ... von D Planchard · · Zitiert von: 137 — ... Eduard Gasal , Libero Santarpia , Bruce E. Johnson. Afficher plus de détails. 1 IGR - Institut Gustave Roussy 2 Département de médecine ...
Veröffentlichungen allgemein
unlocking the potential of viruses to help target cancerSpringer
link.springer.com
von O Hamid · · Zitiert von: 75 — Eduard Gasal was an employee of and stockholder in Amgen Inc. at the time the manuscript was written. Richard D. Carvajal has been a ... von O Hamid · · Zitiert von: 75 — Eduard Gasal was an employee of and stockholder in Amgen Inc. at the time the manuscript was written. Richard D. Carvajal has been a ...
Five-Year Analysis of Dabrafenib Plus Trametinib in ...AIOM
www.aiom.it
Eduard Gasal,10 Matthew Squires,11 Mahtab Marker,10 Jan C. Brase,11 David Polsky David Polsky. 1NYU Langone Medical Center, New York, NY; 2Melanoma ... Eduard Gasal,10 Matthew Squires,11 Mahtab Marker,10 Jan C. Brase,11 David Polsky David Polsky. 1NYU Langone Medical Center, New York, NY; 2Melanoma ...
Artikel & Meinungen
Reimagining patient-centric cancer clinical trials: a multi- ...Nature
www.nature.com
von BT Li · · Zitiert von: 22 — Eduard Gasal. Janssen, Johnson and Johnson, New Brunswick, NJ, USA. Craig Tendler. BeiGene USA, BeiGene, Beijing, China. Geoffrey Kim. Zai Lab ... von BT Li · · Zitiert von: 22 — Eduard Gasal. Janssen, Johnson and Johnson, New Brunswick, NJ, USA. Craig Tendler. BeiGene USA, BeiGene, Beijing, China. Geoffrey Kim. Zai Lab ...
Sonstiges
Anaveon announces first patient dosed with ANV419 in a ...Yahoo Finance Singapore
sg.finance.yahoo.com
— ... Eduard Gasal, MD, Chief Medical Officer at Anaveon. “In patients with multiple myeloma, the critical role of NK cells has been well — ... Eduard Gasal, MD, Chief Medical Officer at Anaveon. “In patients with multiple myeloma, the critical role of NK cells has been well ...
Dr. Eduard Gasal: Gesprochene Sprachen, Rezensionenswissdoc.net
swissdoc.net
Bei uns finden Sie Informationen über den Arzt Dr. Eduard Gasal, die Adresse, Öffnungszeiten, gesprochene Sprachen und Bewertungen. Bei uns finden Sie Informationen über den Arzt Dr. Eduard Gasal, die Adresse, Öffnungszeiten, gesprochene Sprachen und Bewertungen.
Eduard Gasal's research works | Amgen, CA and other ...ResearchGate
www.researchgate.net
Eduard Gasal's 62 research works with citations and reads, including: Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E ... Eduard Gasal's 62 research works with citations and reads, including: Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E ...
Výsledky vyhledávání - "Eduard Gasal"Akademie věd
katalog.lib.cas.cz
Dirk Schadendorf, Caroline Robert, Antoni Ribas, Reinhard Dummer, Paolo A Ascierto, Georgina V Long, Daniel Gusenleitner, Eduard Gasal, Hussein A Tawbi ... Dirk Schadendorf, Caroline Robert, Antoni Ribas, Reinhard Dummer, Paolo A Ascierto, Georgina V Long, Daniel Gusenleitner, Eduard Gasal, Hussein A Tawbi ...
Eduard Karim Gasal, Zürichbusiness-monitor.ch
business-monitor.ch
Eduard Karim Gasal, from Cham in Zürich; Eduard Gasal, from Cham in Zürich. refresh. Subscribe now Report a data problem. Copyright © business-monitor.ch ... Eduard Karim Gasal, from Cham in Zürich; Eduard Gasal, from Cham in Zürich. refresh. Subscribe now Report a data problem. Copyright © business-monitor.ch ...
在结果中检索 - 中国教育图书进出口有限公司socolar.com
www.socolar.com
Eduard Gasal [48]; Dirk Schadendorf [23]; Antoni Ribas [22]; Caroline Robert ... 作者：Omid Hamid ;Brianna Hoffner ;Eduard Gasal 等. 来源：Cancer ... Eduard Gasal [48]; Dirk Schadendorf [23]; Antoni Ribas [22]; Caroline Robert ... 作者：Omid Hamid ;Brianna Hoffner ;Eduard Gasal 等. 来源：Cancer ...
80 публікаційOUCI
ouci.dntb.gov.ua
... Eduard Gasal, Lawrence T Goodnough. https://doi.org , Expert Review of Hematology, № 5, с Scopus. WoS. Цитувань Eduard Gasal, Lawrence T Goodnough. https://doi.org , Expert Review of Hematology, № 5, с Scopus. WoS. Цитувань ...
ANV419 Add to MyFW+FirstWord Pharma
firstwordpharma.com
... Eduard Gasal as CMO. Ref: FirstWord Pharma. Interests: aldesleukin, ANV419, Amgen, Innovent Biologics, Novartis, Roche, Corporate Affairs. November 30, Eduard Gasal as CMO. Ref: FirstWord Pharma. Interests: aldesleukin, ANV419, Amgen, Innovent Biologics, Novartis, Roche, Corporate Affairs. November 30,
Administration and Handling of Talimogene LaherparepvecNational Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von B Hoffner · · Zitiert von: 25 — Authors. Brianna Hoffner , Gail M Iodice , Eduard Gasal. Affiliations. 1 Angeles Clinic and Research Institute. 2 Columbia University in New York von B Hoffner · · Zitiert von: 25 — Authors. Brianna Hoffner , Gail M Iodice , Eduard Gasal. Affiliations. 1 Angeles Clinic and Research Institute. 2 Columbia University in New York
Analysis from phase 2 and 3 clinical trialsEuropean Journal of Cancer
www.ejcancer.com
... Eduard Gasal, Bijoyesh Mookerjee, Paul B. Chapman. European Journal of Cancer. Volume 125 Pages (January 2020). DOI: j.ejca Eduard Gasal, Bijoyesh Mookerjee, Paul B. Chapman. European Journal of Cancer. Volume 125 Pages (January 2020). DOI: j.ejca
AnaveonThe Org
theorg.com
Gary Phillips' profile picture. Gary Phillips. Chief Business Officer. 0. Eduard Gasal's profile picture · Eduard Gasal. Chief Medical Officer. 7. Stephanie ... Gary Phillips' profile picture. Gary Phillips. Chief Business Officer. 0. Eduard Gasal's profile picture · Eduard Gasal. Chief Medical Officer. 7. Stephanie ...
Author Awards | Faculty Author CelebrationTouro Scholar
touroscholar.touro.edu
... Eduard Gasal, and Vivek Subbiah (Article). Search. Enter search terms: Select context to search: in this series, in this repository, across all repositories Eduard Gasal, and Vivek Subbiah (Article). Search. Enter search terms: Select context to search: in this series, in this repository, across all repositories.
Christine Wurz - Senior Quality Assurance Director at ...The Org
theorg.com
Eduard Gasal's profile picture. Eduard Gasal. Chief Medical Officer. Gary Phillips' profile picture. Gary Phillips. Chief Business Officer. Arkadi Khait's ... Eduard Gasal's profile picture. Eduard Gasal. Chief Medical Officer. Gary Phillips' profile picture. Gary Phillips. Chief Business Officer. Arkadi Khait's ...
Dabrafenib plus trametinib in patients with BRAFV600E- ...UKE
fis.uke.de
... Eduard Gasal and Vivek Subbiah",. note = "Copyright {\textcopyright} Elsevier Ltd. All rights reserved.",. year = "2022",. month = jan,. doi = " Eduard Gasal and Vivek Subbiah",. note = "Copyright {\textcopyright} Elsevier Ltd. All rights reserved.",. year = "2022",. month = jan,. doi = "
Dabrafenib plus trametinib in patients with BRAFV600E-mutant ...Vrije Universiteit Brussel
researchportal.vub.be
... Eduard Gasal, Vivek Subbiah. Medical Genetics · Clinical sciences · https://lmmo.research.vub.be/en/home. Research output: Contribution to journal › Article Eduard Gasal, Vivek Subbiah. Medical Genetics · Clinical sciences · https://lmmo.research.vub.be/en/home. Research output: Contribution to journal › Article ...
Dabrafenib plus trametinib in patients with BRAFV600E-mutated ...Region Hovedstadens forskningsportal
research.regionh.dk
Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer - Authors' reply. Vivek Subbiah, Ulrik Lassen, Eduard Gasal, Paul Burgess, ... Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer - Authors' reply. Vivek Subbiah, Ulrik Lassen, Eduard Gasal, Paul Burgess, ...
Estimation of Distant Metastasis-free Survival in Trials ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von GV Long · · Zitiert von: 3 — Eduard Gasal , Axel Hauschild. Affiliations. 1 Melanoma Institute Australia, Sydney, NSW, Australia .au. 2 Novartis ... von GV Long · · Zitiert von: 3 — Eduard Gasal , Axel Hauschild. Affiliations. 1 Melanoma Institute Australia, Sydney, NSW, Australia .au. 2 Novartis ...
Long-Term Outcomes in Patients With BRAF V600–Mutant ...ASCO Publications
ascopubs.org
Eduard Gasal. Employment: Amgen, Novartis. Stock or Other Ownership: Amgen, Novartis. Travel, Accommodations, Expenses: Amgen, Novartis. Bijoyesh Mookerjee. Eduard Gasal. Employment: Amgen, Novartis. Stock or Other Ownership: Amgen, Novartis. Travel, Accommodations, Expenses: Amgen, Novartis. Bijoyesh Mookerjee.
Long-term outcomes in patients with BRAF V600-mutant ...Elsevier
mayoclinic.elsevierpure.com
von GV Long · · Zitiert von: 246 — ... Eduard Gasal, Bijoyesh Mookerjee, Jeffrey Weber, Keith T. Flaherty. Oncology. Research output: Contribution to journal › Article › peer-review. von GV Long · · Zitiert von: 246 — ... Eduard Gasal, Bijoyesh Mookerjee, Jeffrey Weber, Keith T. Flaherty. Oncology. Research output: Contribution to journal › Article › peer-review.
Long-term outcomes in patients with BRAF V600-mutant ...X-MOL
www.x-mol.com
von A Hauschild · · Zitiert von: 77 — , Richard Kefford o , Tomas Haas p , Anthony D'Amelio Jr. q , Eduard Gasal q , Bijoyesh Mookerjee q , Paul B. Chapman r. Show more. Share. Cite. https ... von A Hauschild · · Zitiert von: 77 — , Richard Kefford o , Tomas Haas p , Anthony D'Amelio Jr. q , Eduard Gasal q , Bijoyesh Mookerjee q , Paul B. Chapman r. Show more. Share. Cite. https ...
Verwandte Suchanfragen zu Eduard Gasal
| Paul Burgess Claudia Schusterbauer Daniel Gusenleitner |
Personen Vorname "Eduard" (8880) Name "Gasal" (6) |
sortiert nach Relevanz / Datum